ABCL Live signals | Maximize Profits with Getagraph.com

SELL 103633 min ago

@ $5.26

Issued: 14 Feb 2024 @ 14:38

Return: -29.02%

Previous signal: Feb 14 - 12:00

Previous signal: Buy

Return: 1.06 %

Live Chart Being Loaded With Signals

Commentary (26 Apr 2024 @ 14:50):

Stats
Today's Volume	909 040
Average Volume	1.36M
Market Cap	1.09B
EPS	$0 ( 2024-02-20 )
Next earnings date	( $-0.160 ) 2024-05-02
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-7.31
ATR14	$0.0110 (0.29%)

Insider Trading

Date	Person	Action	Amount	type
2024-02-26	Hansen Carl L. G.	Sell	56 125	Share option (right to buy)
2024-02-26	Hansen Carl L. G.	Buy	56 125	Common Shares
2024-01-14	Lecault Veronique	Buy	770 416	Share option (right to buy)
2024-01-14	Stimart Tryn	Buy	616 333	Share option (right to buy)
2024-01-14	Booth Andrew	Buy	770 416	Share option (right to buy)

INSIDER POWER
79.73
Last 95 transactions
Buy: 16 009 839 \| Sell: 26 316 378

Volume Correlation

Long: 0.18 (neutral)

Short: -0.39 (neutral)

Signal:(41.382) Neutral

AbCellera Biologics Inc. Correlation

10 Most Positive Correlations
SVAC	0.967
STOK	0.963
CROX	0.96
GSIT	0.957
CTXR	0.957
VIR	0.955
JBLU	0.954
TPIC	0.953
FGEN	0.952
CUE	0.951

10 Most Negative Correlations
RMBS	-0.984
NETE	-0.973
AMRB	-0.972
MMAC	-0.956
BRIVU	-0.952
SCR	-0.95
MSDA	-0.95
IMOS	-0.949
KE	-0.948
EBSB	-0.947

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

AbCellera Biologics Inc. Correlation - Currency/Commodity

0.02
( neutral )

0.53
( weak )

0.00
( neutral )

0.59
( weak )

0.00
( neutral )

-0.61
( weak negative )

AbCellera Biologics Inc. Financials

Annual	2023
Revenue:	$38.03M
Gross Profit:	$7.13M (18.75 %)
EPS:	$-0.510

FY	2023
Revenue:	$38.03M
Gross Profit:	$7.13M (18.75 %)
EPS:	$-0.510

FY	2022
Revenue:	$485.42M
Gross Profit:	$418.99M (86.31 %)
EPS:	$0.560

FY	2021
Revenue:	$375.20M
Gross Profit:	$329.69M (87.87 %)
EPS:	$0.960

Financial Reports:

No articles found.

AbCellera Biologics Inc.

AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in progress, or under contract with 36 partners. AbCellera Biologics Inc. has a research collaboration and license agreement with Eli Lilly and Company. The company was incorporated in 2012 and is headquartered in Vancouver, Canada.